Avicenna.AI secures FDA clearance for two healthcare AI solutions

PRWeb
This post was originally published on this site

Medical imaging AI company receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity. La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ — Medical imaging AI company Avicenna.AI today announced that it has received 510(k)…